Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
Neuropathic Pain and Pharmacological Treatment.
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial.
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
Central sensitization in patients with rheumatoid arthritis: a systematic literature review.
In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome.
Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma.
Serotonergic descending inhibition in chronic pain: design, preliminary results and early cessation of a randomized controlled trial.
The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy.
A C-fiber-mediated neuropathic brachioradial pruritus.
Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases.
Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
Nociceptive sensitization by endothelin-1.
Altered sensitivity to mechanical stimulation during prolonged subcutaneous administration of endothelin-1 in rats.
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Transdermal buprenorphine - a critical appraisal of its role in pain management.
Endothelin-1-induced pain and hyperalgesia: a review of pathophysiology, clinical manifestations and future therapeutic options.
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Neurosensory changes in a human model of endothelin-1 induced pain: a behavioral study.
Buprenorphine--a review of its role in neuropathic pain.
The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study.